tirzepatide court decision The Legal Battle Over Tirzepatide: Compounders Sue the FDA FDA says the tirzepatide weight-loss

AR-G: Investigation, Writing review & editing, Data curation

Thats comparable to results seen with bariatric surgerywithout the surgery

*These statements have not been evaluated by the U

Common: nausea, diarrhea, vomiting, indigestion, constipation Other possible: burping, fatigue, stomach pain, hair loss, injection site reactions, dizziness Serious (seek immediate care): Allergic reactions: hives, throat/tongue swelling, breathing difficulty Thyroid tumors: neck lump, hoarseness Pancreatitis: severe abdominal pain, vomiting Kidney injury: dehydration signs, low urine output Gallbladder issues: upper abdominal pain, fever Hypoglycemia: shakiness, confusion when combined with insulin or sulfonylureas Diabetic retinopathy worsening: vision changes Depression or suicidal thoughts Is there a Boxed Warning with Zepbound

This also applies to expired tirzepatide products that may have been relabeled with new expiration dates

FDA labeling for stimulants recommends assessing for cardiac disease before starting therapy and monitoring vital signs